MediciNova Inc (NASDAQ:MNOV) shares fell 14. 7% in premarket trading on Monday after the company reported topline results ...

The vitamin D supplement you take every day. It was recommended by your doctor because it is 'scientifically backed.' The study that served as the basis: a large-scale randomized controlled trial of ...

Almost every diet study reports "statistically significant weight loss." Yet, almost no one who lives their life according to those exact study methods manages to maintain that weight a few years ...

CBL-514 delivered statistically significant pain reduction across both FAS and PP populations compared with placebo.

BioVie (NASDAQ:BIVI) shares fell nearly 9. 7% in premarket trading after the company reported results from its Phase 2 ADDRESS-LC trial evaluating bezisterim for neurological symptoms associated with ...

Shares of MediciNova declined after topline results from a Phase 2 trial for the company's potential treatment for hypertriglyceridemia and nonalcoholic fatty liver disease did not show statistical ...

Higher blood levels of a marker of nerve damage are associated with lower daily activity in people with progressive forms of ...

Childhood obesity remains a pressing global health challenge, yet the impact of dynamic adiposity changes during active developmental window retains poorly understood. Leveraging longitudinal data ...

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.

What you are not permitted to do under the federal securities laws is take that negative data, rewrite the grading rubric twenty-four hours before unblinding the results, tell the public you have ...

Interim analysis crossed futility, indicating proton therapy was unlikely to demonstrate an overall survival benefit versus photons if accrual and follow-up continued. Median overall survival favored ...

BACKGROUND: Epigenetic mechanisms underlying susceptibility to abdominal aortic aneurysm (AAA) remain poorly understood.